Related Experiment Video
Updated: Aug 4, 2026

13:33
Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
41.3K
Evaluation of HLA-DRB1 imputation using a Finnish dataset
E Vlachopoulou1, E Lahtela, A Wennerström
1Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, FI-00014, Finland.
Tissue Antigens
|March 27, 2014
Summary
Computational human leukocyte antigen (HLA) imputation using HLA*IMP and SNP2HLA showed low success rates for HLA-DRB1 alleles in a Finnish cohort. Population-specific reference data is crucial for accurate HLA imputation.
Area of Science:
- Genetics and Genomics
- Immunogenetics
- Computational Biology
Background:
- High-resolution human leukocyte antigen (HLA) typing is essential for various medical applications but is costly and time-consuming due to the high number of alleles.
- Computational methods for HLA imputation aim to reduce costs and time by predicting HLA alleles from genetic data.
Purpose of the Study:
- To evaluate the reliability of two computational tools, HLA*IMP and SNP2HLA, for imputing HLA-DRB1 alleles.
- To assess the imputation accuracy in a specific Finnish population, considering its unique genetic background.
Main Methods:
- Tested HLA*IMP and SNP2HLA software for imputing HLA-DRB1 alleles in a Finnish cohort of 161 individuals.
- Analyzed per-individual success rates and identified commonly misimputed alleles.
Main Results:
- Both HLA*IMP and SNP2HLA demonstrated low per-individual success rates for HLA-DRB1 imputation, ranging from 16.68% to 25.4%.
- The common HLA-DRB1*01:01 allele was frequently misimputed, with an approximate 30% success rate.
- Finnish population's distinct haplotype frequencies, shaped by isolation and migration, may influence imputation accuracy compared to broader European datasets.
Conclusions:
- Current computational imputation methods show limited reliability for HLA-DRB1 alleles in the Finnish population.
- The findings underscore the critical need for population-specific reference panels to improve the accuracy of HLA imputation.

